Quick Links

Publications by our members

A list of selected publications (since 2005) on subjects related to health and law from our group members. Click on each name to view each person's list of publications.

Angela Campbell

Plus ça change…? Bountiful’s Diverse and Durable Marriage Practices” in Lori Beaman & Gillian Calder, eds, Polygamy's Rights and Wrongs: Perspectives on Harm, Family and Law (Vancouver: UBC Press, 2014) 21.

Sister Wives, Surrogates and Sex Workers: Outlaws by Choice? (Farnham, UK: Ashgate, 2013).

with Franco Carnevale, Delphine Collin-Vézina & Mary Ellen Macdonald, “Interdisciplinary Studies of Childhood Ethics: Developing a New Field of Inquiry” (2013) Children and Society DOI: 10.1111/chso.12063.

“Examining Law’s Suppositions about Surrogacy against the Backdrop of Social Science” Ottawa Law Review (March 2012).

“Averting Misconceptions: Judicial Analyses of Family Disputes over Stored Embryos” in National Judicial Institute, Proceedings of the National Judicial Institute Family Law Seminar (February 2012).

“Exploring Judicial Appreciations of Parental Addiction in Child Custody and Access Decisions: Quebec as a Case Study” (2010) 28 Windsor Review of Legal and Social Issues 1.

with  P. B. Miller & S. Choudhry, “Primer on the Legal Relationship of the Physician-Patient Relationship” in the Bioethics Curriculum Project of the Royal College of Physicians and Surgeons of Canada (2009). 

“Ethos and Economics: Examining the Rationale Underlying Stem Cell and Cloning Research Policies in the U.S., Germany and Japan” (2005) 31 American Journal of Law and Medicine 47-86.

"Pathways to and from the Supreme Court of Canada for Health Law Litigants" in Jocelyn Downie and Elaine Gibson, eds. Health Law at the Supreme Court of Canada (Toronto: Irwin Law, 2007).

with Gillian Nycum. "Harmonizing the International Regulation of Embryonic Stem Cell Research: Possibilities, Promises and Potential Pitfalls" (2005) 7 Medical Law International 113.

Anne Crocker

with A Prokic et al, “Intellectual disability and co-occurring mental health and physical disorders in aggressive behaviour” (2013) 58:11 J Intellect Disabil Res 1032.

with D Morin et al, “Public attitudes towards intellectual disability: a multidimensional perspective” (2013) 57:3 J Intellect Disabil Res 279.

with G Côté & E Brathwaite, “L’évaluation et la gestion du risque de violence” in T Lecomte & C Leclerc, eds, Intervention de pointe en réadaptation psychiatrique, 2nd ed (Montreal: Presses de l’Université du Québec, 2012) 275.

with L LeBlanc et al, “Profils d’évolution des personnes atteintes de troubles mentaux graves qui reçoivent des services de suivi communautaire” (2012) 31(1) Revue canadienne de santé mentale communautaire 33.

with G Côté & E Braithwaite, “Perspectives in violence risk assessment and management in mental health services’ in E Vyngilis & S State, eds, Applied research and evaluation in community mental health services: An update of key research domains (McGill-Queens University Press, 2011) 94.

with Y Charette & I Billette, “The judicious judicial dispositions juggle: characteristics of police interventions involving people with a mental illness” (2011) 56:11 Can J Psychiatry 677.

with E Braithwaite et al, “To detain or to release? Correlates of dispositions for individuals declared not criminally responsible on account of mental disorder” (2011) 56:5 Can J Psychiatry 293.

with E Braithwaite et al, “START Changing Practice: Implementing a Risk Assessment and Management Tool in a Civil Psychiatric Setting” (2011) 10:1 Int J Forensic Ment Health 13.

with E M Jansman-Hart et al, “International Trends in Demand for Forensic Mental Health Services” (2011) 10:4 Int J Forensic Ment Health 326.

with C Mercier “The first critical steps through the criminal justice system for persons with intellectual disabilities” (2011) 39:2 Brit J Learn Disabil 130.

with G Côté, “Troubles mentaux et comportement violent: de la dangerosité à l'évaluation et à la gestion du risque” in M Leblanc & M Cusson, eds, Traité de criminologie empirique (Montreal: Les Presses de l’Université de Montréal, 2010) 503.

with T N Nicholls et al, “Individuals found not criminally responsible on account of mental disorder: Are we providing equal protection and equivalent access to mental health services to accused mentally ill individuals across Canada?” (2010) 29:2 Canadian Journal of Community Mental Health 1.

with E Braithwaite et al, “The predictive validity of clinical ratings of the Short-Term Assessment of Risk and Treatability (START)” (2010) 9:4 International Journal of Forensic Mental Health 271.

with G Côté, “Violence et maladie mentale : Vaincre la stigmatisation sans souffrir du syndrome de l’autruche” (2010) 19:1 Le Partenaire 4.

with A Jaimes, “Réussites et défis du programme d’accompagnement justice et santé mentale: un regard sur la première année de fonctionnement” (2010) 19:1 Le Partenaire 14.

“Santé mentale et la Loi : enjeux d’ordre éthique, scientifique et d’organisation des services” (2009) 34:2 Revue Santé mentale au Québec 7.

with A Jaimes et al, “Au croisement de la justice et de la santé mentale : Objectifs, enjeux et limites des Tribunaux de santé mentale” (2009) 34:2 Revue Santé Mentale au Québec 171.

with D Ambrosini, “Psychiatric advance directives and the role of autonomy” (2009) 34:2 Revue Santé Mentale au Québec 51.

with L K Frisman et al, “Use of IDDT via ACT versus clinical case management for persons with co-occurring disorders and Anti-Social Personality Disorder” (2009) 197:11 Journal of Nervous and Mental Disease 822.

with G Côté, “Evolving systems of care: Individuals found not criminally responsible on account of mental disorder in custody of civil and forensic psychiatric settings” (2009) 24 European Psychiatry, 356.

with D L Ambrosini et al, “Perceptions of psychiatric advance directives among legal and mental health professionals” (2008) 3:1 Journal of Ethics in Mental Health 1.

with G Côté & M Moscato, “L’évaluation et la gestion du risque de comportements violents : De la clinique spécialisée à la pratique clinique générale” (2008) 29:1 Revue Québécoise de Psychologie 137. 

with C Mercier et al, “Profiles and correlates of aggressive behaviour among individuals with intellectual disabilities” (2007) 51 Journal of Intellectual Disability Research 786.

with D L Ambrosini, “Psychiatric advanced directives and the right to refuse treatment in Canada” 52:6 Canadian Journal of Psychiatry 397.

with G Côté et al, “Rate and characteristics of men with an intellectual disability among pre-trial detainees” (2007) 32:2 Journal of Intellectual and Developmental Disabilities 143.

with K T Mueser et al, “Conduct disorder and antisocial personality disorder in persons with severe psychiatric and substance use disorders” (2006) 32:4 Schizophrenia Bulletin 626.

with C Mercier et al, “Prevalence and characteristics of aggressive behaviour among adults with intellectual disabilities” (2006) 50:9 Journal of Intellectual Disability Research 652.

with K T Mueser et al, “Antisocial personality, psychopathy and violence in persons with dual disorders: A longitudinal analysis” (2005) 32:4 Criminal Justice and Behavior 452.

Pierre Deschamps

« L’aide médicale à mourir ou l’instrumentalisation du droit à des fins politiques : lorsque la fin justifie les moyens » dans La protection des personnes vulnérables 2015, Montréal, Yvon Blais, 2015, 61.

« Éthique de la recherche » dans Mélanie Bourassa Forcier et Anne-Marie Savard, dir, Droit et politiques de la santé,  Montréal, LexisNexis, 2014, 499.

« L’intégrité » dans Personnes et famille, JurisClasseur Québec, Montréal, LexisNexis, 2014, fascicule 2.

« La confiscation des droits fondamentaux des personnes inaptes et les régimes de protection » dans La protection des personnes vulnérables 2013, Montréal, Yvon Blais, 2013, 67.

« Pour le développement d’une approche systémique en matière de protection des sujets de recherche » dans Michel Carrier et Danielle Laudy, dir, Questions d’éthique : La recherche médicale de la naissance à l’âge adulte, Montréal, Éditions du CHU Sainte-Justine, 2012, 219.

“A New Perspective on Research Ethics” (2011) 19 Health L Rev 25.

« L’État doit-il s’occuper ou se préoccuper des personnes vulnérables? » dans École du barreau du Québec, dir, Responsabilité - Collection de droit 2010-2011, Cowansville (Qc), Yvon Blais, 2010, 33.

“Ethics Review of Multi-Centre Trials: Where Do We Stand?” (2009) 17 Health L Rev 59.

« La protection des données personnelles recueillies aux fins de recherche : enjeux éthiques et juridiques » Atelier sur l’utilisation des données de recherche numérisées en sciences humaines : enjeux éthiques, juridiques et patrimoniaux, présenté à l’Université de Sherbrooke, mars 2006.

Yann Joly

with S O M Dyke, W A Cheung et al, “Epigenome data release: a participant-centered approach to privacy protection” (2015) 16:1 Genome Biology 142, available online.

with G Berthier and M H Zawati, “The Role of Whole Genome and Whole Exome Sequencing in Preventive Genomic Sequencing Programs” (2015) 15:7 American Journal of Bioethics 22.

with S O M Dyke, W A Cheung et al, “Risk of re-identification of epigenetic methylation data: a more nuanced response is needed” (2015) 7:1 Clinical Epigenetics 45, available online.

with P Granados Moreno, “Intellectual Property Rights in Translation” in M Wehling, ed, Principles of Translational Science in Medicine. From Bench to Bedside, 2nd ed (Oxford: Elsevier, 2015) 281.

with E S Dove & B M Knoppers, “International genomic cloud computing – ‘Mining’ the Terms of Service” in A Cheung & R Weber, eds, Privacy and Legal Issues in Cloud Computing (Cheltenham Glos, UK: Edward Elgar Publishing, 2015) 261.

with I Ngueng Feze & S Salman, “Implications for Health and Life Insurances and Other Legal Aspects of Genetic Testing” in S A Schneider & J M Tomas-Bras, eds, Movement Disorder Genetics (Cham, Switzerland: Springer, 2015) 499.

with A Thorogood et al, “An Implementation Framework for the Feedback of Individual Research Results and Incidental Findings in Research” (2014) 15:1 BioMed Central Medical Ethics 88, available online.

with I Ngueng Feze, N Prystajecky et al, “The regulation of novel water quality assessment biotechnologies: Is Canada ready to ride the next wave?” (2014) 26:3 Journal of Environmental Law and Practice 201.

with V Ragoussis and I Ngueng Feze, “Sharing Genetic Information Online: An Exploration of GINA’s 2.0 Frontier” (2014) 14:11 The American Journal of Bioethics 53-55.

with G Dalpé, “Opportunities and Challenges Provided by Cloud Repositories for Bioinformatics-Enabled Drug Discovery” (2014) 75:6 Drug Development Research 393.

with E S Dove, A-M Tassé, et al, “Genomic cloud computing: legal and ethical points to consider” (2014) European Journal of Human Genetics DOI: 10.1038/ejhg.2014.196, available online.

with E Moher, S Nicholls et al, “Genetic discrimination and insurance in Canada: Where are we now” (2014) 30:3 On the Risk, Journal of The Academy of Life Underwriting 46, available online.

with K M Saulnier, G Osien & B M Knoppers, “The ethical framing of personalized medicine” (2014) 14:5 Current Opinion in Allergy & Clinical Immunology 404.

with D Milius et al, “The International Cancer Genome Consortium’s evolving data protection policies” (2014) 32:6 Nature Biotechnology 519.

with P Tonin, “Social, ethical and legal considerations raised by the discovery and patenting of the BRCA1 and BRCA2 genes” (2014) 33:2 New Genetics and Society 167.

with M Lévesque et al, “Stem Cell Research Funding Policies and Dynamic Innovation: A Survey of Open Access and Commercialization Requirements” (2014) 10:4 Stem Cells Reviews and Reports 455, available online.

with T Caulfield, S Burningham et al, “A Review of the Key Issues Associated with the Commercialization of Biobanks” (2014) 1:1 Journal of Law and the Biosciences 94, available online.

with U Ogbogu et al, “Policy recommendations for addressing privacy challenges associated with cell-based research and interventions” (2014) 15:7 BMC Medical Ethics 1, available online.

with H Burton, B M Knoppers et al, “Life Insurance: Genomic Stratification and Risk Classification” (2014) 22:5 European Journal of Human Genetics 575, available online.

with R Kim, S Salman & I Ngueng Feze, “The use of Genetic Information Outside of the Therapeutic Health Relationship: An International Perspective” in G Quinn, A De Paor & P Blanck, eds, Genetic Discrimination Transatlantic Perspectives on the Case for a European Level Legal Response (Oxford: Routledge, 2014) 68.

with B M Knoppers, eds, Routledge Handbook of Medical Law and Ethics (Oxford: Routledge, 2014).

with G Dalpé, “Towards precision medicine: the legal and ethical challenges of pharmacogenomics” in Y Joly & B M Knoppers, eds, Routledge Handbook of Medical Law and Ethics (Oxon: Routledge, 2014) 339.

with V Rahimzadeh & B M Knoppers, “Introduction” in Y Joly & B M Knoppers, eds, Routledge Handbook of Medical Law and Ethics (Oxon: Routledge, 2014) 1.

with I Ngueng Feze, S Salman & B M Knoppers, “Submission to the Standing Senate Committee on Legal and Constitutional Affairs regarding Bill S-201, An Act to prohibit and prevent genetic discrimination” (2014) Centre of Genomics and Policy, available online.

with C Cook et al, “A comparison of the regulatory frameworks governing microbial testing of drinking water in three Canadian provinces” (2013) 38:3 Canadian Water Resources Journal 185.

with C Allen & P Granado, “Data sharing, Biobanks and Informed Consent; A Research Paradox?” (2013) 7:1 McGill Health Law Journal 85, available online.

with T Caulfield et al, “Reflections on the Cost of ‘Low-Cost’ Whole Genome Sequencing: Framing the Health Policy Debate” (2013) 11:11 PLoS Biology 1, available online.

with D So, “Commercial opportunities and ethical pitfalls in personalized medicine: a myriad of reasons to revisit the Myriad Genetics saga” (2013) 11:2 Pharmacogenomics and Personalized Medicine 98, available online.

with T Caulfield, S Chandrasekharan & B Cook-Deegan, “Harm, hype and evidence: ELSI research and policy guidance” (2013) 5:3 Genome Medicine 1, available online.

with I Ngueng-Feze & J Simard, “Genetic Discrimination and Life Insurance: A Systematic Review of the Evidence” (2013) 11:25 BMC Medicine 1, available online.

with D Avard, “Pharmacogenomics: Ethical, Legal and Social Issues” in I S Vizirianakis, ed, Handbook of Personalized Medicine: Advances in Nanotechnology, Drug Delivery and Therapy (Singapore: Pan Stanford Publishing, 2013) 813.

with B M Knoppers, “Ethics and Genetics” in S Maloy & K Hughes, eds, Brenner’s Encyclopedia of Genetics, 2nd ed (Oxford: Elsevier, 2013) 528.

with V Ozdemir, E Kirby et al, “Beyond ELSIs - Where to From Here? From ‘Regulators’ to Anticipating and Shaping the Innovation Tranjectory in Personalized Medicine” in Y W Lam & L Cavallari, eds, Pharmacogenomics: Challenges and Opportunities in Therapeutic Implementation (Oxford: Elsevier, 2013) 371.

with C Romeo-Casabona, P Nicolas et al, “Legal Aspects of Genetic Databases for International Biomedical Research: The Example of the International Cancer Genome Consortium (ICGC)” (2012) 37 Law and the Human Genome Review 15.

with E S Dove & V Ozdemir, “Harnessing Omics Sciences, Population Databases, and Open Innovation for Theranostics-Guided Drug Discovery and Development” (2012) 73:7 Drug Development Research 439.

with E S Dove, “The Contested Futures of Biobanks and Intellectual Property” (2012) 11 Teoria y Derecho 132, available online.

with V Ozdemir, BM Knoppers et al, “Are We Asking the Right Ethics Questions on Drug Shortages? Suggestions for a Global and Anticipatory Ethics Framework” (2012) 12:1 The American Journal of Bioethics 13.

with C Allen & B M Knoppers, “Currents in Contemporary Bioethics. Open Access as Benefit Sharing? The Example of Publicly Funded Large-Scale Genomic Databases” (2012) 40:1 Journal of Law Medicine and Ethics 143.

with I Ngueng Feze, “Droit et pharmacogénomique à la recherche d’une parfaite alchimie” in L Lalonde, ed, Le droit, vecteur de la gouvernance en santé? Défis théoriques et enjeux pratiques (Sherbrooke, QC: Les Éditions Revue de droit de l’Université de Sherbrooke, 2012) 261.

“Propriété intellectuelle et modèles de collaboration ouverte” in P-E Moyse, ed, JurisClasseur Québec Propriété Intellectuelle (Montreal: LexisNexis Canada, 2012) 3/1.

with F Hemmings, “Bilski v. Kappos and biotechnology patents: Back to the future?” in M Rimmer & A McLennan, eds, Intellectual Property and Emerging Technologies: The New Biology (Cheltenham, UK & Northampton, Mass: Edward Elger Publishing, 2012) 63.

with A Livingston & E dove, Moving Beyond Commercialization: Strategies to Maximize the Economic and Social Impact of Genomic Research (Ottawa: Genome Canada, 2012), Available online.

with E Lévesque & J Simard, “Return of research results: General principles and international perspectives” (2011) 39:4 Journal of Law Medicine and Ethics 583.

with M H Zawati & M Hendy, “Incidental Findings in Data-Intensive Postgenomics Science and Legal Liability of Clinician-Researchers: Ready for Vaccinomics?” (2011) 15:9 OMICS: A Journal of Integrative Biology 615.

with G Koutrikas, E Ramos-Paque et al, “Diagnostic Testing for Vaccinomics: Is the Regulatory Approval Framework Adequate?” (2011) 15:9 OMICS: A Journal of Integrative Biology 597.

with H C Howard, D Avard et al, “Informed Consent in the Context of Pharmacogenomic Research: Ethical Considerations” (2011) 11:3 The Pharmacogenomics Journal 155.

with N Zeps & B M Knoppers, “Genomic Databases Access Agreements: Legal Validity and Possible Sanctions” (2011) 130:3 Human Genetics 441.

with G Koutrikas, A-M Tassé et al, “Regulatory Approval for New Pharmacogenomics Tests: A Comparative Overview” (2011) 66:1 Food and Drug Law Journal 1.

with S Pathmasiri, M Deschênes et al, “Intellectual Property Rights in Publicly Funded Biobanks: Much Ado About Nothing?” (2011) 29:4 Nature Biotechnology 319.

with A-M Tassé & E Dove, Balancing Privacy Protections with Open, Collaborative, Biomedical Research: Implications for Updatingthe CIHR Privacy Best Practices Document (Ottawa: CIHR, 2011).

with E Ramos-Paque, “Approval of New Pharmacogenomic Tests: Is the Canadian Regulatory Process Adequate?” (2010) 8:2 Canadian Journal of Law and Technology 215, online available online.

with M Braker & M Le Huynh, “Genetic Discrimination in Private Insurance: Global Perspectives” (2010) 29:4 New Genetics and Society 351.

“Clinical Translation of Stem Cell Therapies – Intellectual Property and Anticipatory Governance” (2010) 7:2 SCRIPTed 265.

“Open Biotechnology: Licenses Needed” (2010) 28:5 Nature Biotechnology 417.

with K A McClellan & B M Knoppers, “Personalized Vaccines and Public Health Genomics: Anticipating and Monitoring the ELSIs” (2010) 8:1 Current Pharmacogenomics and Personalized Medicine 4.

“En terre étrangère … ou, les aventures d’un juriste au pays de l’éthique de la recherche” in M S Jean & P Trudel, eds, La malréglementation : Une éthique de la recherche est-elle possible et à quelles conditions? (Montréal: Les Presses de l’Université de Montréal, 2010) 41.

with T Caulfield, “Human Gene Patents and Genetic Testing” in G Patrinos & W Ansorge, eds, Molecular Diagnostics, 2nd ed (Burlington: Academic Press, 2010) 399.

with L Bently et al, Exclusions from Patentability and Exceptions and Limitations to Patentees’ Rights (Geneva: WIPO, 2010).

with R Gold, The Patent System and Research Freedom: A Comparative Study (Geneva: WIPO, 2010), available online

with B M Knoppers, General Problems Related to the Collection and Processing of Health Related Information for Insurance Purposes Including Those Which Are Specific to Predictive Health Data (Strasbourg: Council of Europe, 2010).

with T Bubela et al, Evidence and Background Information to Inform Canada’s Approach to Public Health and Intellectual Property Issues in International Fora (Montreal: Submission to Health Canada’s International Affairs Directorate, 2010).

with E R Gold et al, At the intersection of health and intellectual property: Issues, tools and directions for Health Canada (Montreal: Submission to Health Canada Bioethics, Innovation and Policy Integration Division, 2010).

with T Caulfield et al, “The Stem Cell Research Environment: a Patchwork of Patchworks” (2009) 5:2 Stem Cells Reviews and Reports 82.

“Intellectual Property and the ‘Right’ to Health in the Age of Biomedicine” in A-M Duguet, I Filippi & J Herveg, eds, Accès aux transplantations d’organes et de tissus en Europe et droits aux soins en Europe, Séminaire d’actualité de droit médical (Bordeaux: Les Études Hospitalières, 2009) 119.

with B M Knoppers, General Problems Related to the Collection and Processing of Health Related Information for Insurance Purposes Including those which are Specific to Predictive Health Data (Montreal: Council of Europe, 2009).

The Toronto Data Release Workshop (Ottawa: Genome Canada, 2009).

with C Frank et al, Making an Impact: A Preferred Framework and Indicators to Measure Returns on Investment in Health Research (Ottawa: Canadian Academy of Health Sciences, 2009).

“Genetic Research Tools: Recent trends and future outlook” in B M Knoppers & E R Gold, eds, Biotechnology IP & Ethics (Markham: LexisNexis Canada, 2009) 2.

with T Silverstein, E Harmsen & B M Knoppers for the Gene Regulators in Disease Project, “The Commercialization of Academic Research in Genomics: Conflicting Interests?” in B M Knoppers & E R Gold, eds, Biotechnology IP & Ethics (Markham: LexisNexis Canada, 2009) 131.

“L’utilisation des ressources biologiques humaines et le partage des avantages: à la recherche d’un nouvel équilibre” in F Bellivier & C Noiville, eds, La bioéquité : batailles autour du partage du vivant (Paris: Éditions Autrement, 2009) 39.

with D Avard, “Improved Understanding of Genetic and Genomic Influences on Drug Disposition and Action - Implications for Children” (2008) 10:5 Pediatric Drugs 275.

with S Sillon, S Feldman & D Avard, “An Ethical and Legal Overview of Pharmacogenomics: Perspectives and Issues” (2008) 27:4 Medicine and Law 843.

with G Sillon, T Silverstein et al, “Pharmacogenomics: Don’t Forget the Children” (2008) 6:2 Current Pharmacogenomics and Personalized Medicine 77-84, available online

with M A Rothstein, “Genetic Information and Insurance Underwriting: Contemporary Issues and Approaches in the Global Economy Insurance” in P Atkinson, P Glasner & M Lock, eds, Property and Privacy, Handbook of Genetics and Society Mapping the New Genomic Era (New York: Routledge, 2008) 127.

“Open Source Biotechnology: Refocusing the Debate” in N Sudarshan, ed, Biotechnology: a Legal Approach (Punjagutta: The Icfai University Press, 2008) 40.

with B M Knoppers, eds, La santé et le bien commun (Montréal : Les Éditions Thémis, 2008).

with B M Knoppers, “La connaissance du génome : un instrument au service de l’humanité?” in B M Knoppers & Y Joly, eds, La santé et le bien commun (Montreal : Les Éditions Thémis, 2008) 249.

with G Nycum, “Currents in Contemporary Ethics: The Tuberculosis Scare in Retrospect” (2007) 35:4 Journal of Law, Medicine & Ethics 734.

with MS Phillips, T Silverstein & D Avard, “Consent in Pharmacogenomic Research” (2007) 5:2 GenEdit 1.

“Open Source Approaches in Biotechnology: Utopia Revisited” (2007) 59:2 Maine Law Review 385, available online.

with B M Knoppers, “Our Social Genome?” (2007) 25:7 TRENDS in Biotechnology 284.

“L’accès à l’information génétique contenu dans dossier médical par les assureurs sur la vie : un besoin de repositionner le débat” in A M Duguet & I Filippi, ed, Séminaire d’actualité de droit médical – dossier médical et données médicales de santé : protection de la confidentialité, condition d’accès, échanges pour les soins et la recherche (Bordeaux: Les Études Hospitalièrse, 2007).

with B McGillivray et al, Options for Improving Public Access to Information on Health Products Clinical Trials in Canada (Ottawa: Health Canada, 2007).

with D Schorno, “Le brevet : valet ou maître du droit à la santé?” (2006) 19:2 Revue québécoise de droit international 65, available online.

with BM Knoppers, J Simard & F Durocher, “The Emergence of an Ethical Duty to Disclose Genetic Research Results” (2006) 14:12 European Journal of Human Genetics, 1322.

“Wind of Change: In Re Fisher and the Evolution of the American Biotechnology Patent Law” (2006) 24:1 Law in Context 67.

“Life Insurers' Access to Genetic Information: A Way out of the Stalemate” (2006) 14:3 Health Law Review 14.

with B M Knoppers, “Pharmacogenomic Data Sample Collection and Storage:  Ethical Issues and Policy Approaches” (2006) 7:2 Pharmacogenomics, 219-226.

with E R Gold & T Caulfield, “Genetic Research Tools, the Research Exception and Open Science” (2005) 3:2 GenEdit 1, available online .

“Biotechnologies et brevets : le cas de la pharmacogénomique” (2005) 10:2 LexElectronica 1, available online .

with B M Knoppers & M T Nguyen, “Stored tissue samples: Through the confidentiality maze” (2005) 5:1 The Pharmacogenomic Journal 2, available online>.

with J Simard et al, “Les enjeux éthiques du partage des résultats de recherche : L’expérience d’INHERIT BRCAs” in S Philips-Nootens, B Godard et al, eds, La recherche en génétique et en génomique : droits et responsabilités (Montreal: Les Éditions Thémis, 2005) 103.

with H Mbulu, “L’utilisation des échantillons et de l’information des cadavres en recherche biomédicale : Perspectives québécoises et internationales” in A M Duguet & I Filippi, eds, Séminaire d’actualité et de droit médical – Droit et éthique de la recherche médicale (Bordeaux: Les Études Hospitalières, 2005) 229.

“Le génome comme outil de recherche? Principaux courants et enjeux nord-américain” in C Hervé, B M Knoppers et al, eds, Place de la bioéthique en recherche et dans les services cliniques (Paris: Dalloz, 2005) 91.

Derek J. Jones

Jones DJ, Bush PL, Macaulay AC. "PDF icon Beyond Consent: Respect for Community in Genetic Research", In eLife Sciences (eLS) John Wiley Sons Ltd, 2014.

Jones DJ, Barkun AN, Lu Y et al, "PDF icon Conflicts of Interest Ethics: Silencing Expertise in the Development of International Clinical Practice Guidelines". Ann Intern Med 2012;156(11):809-16.

Jones, DJ & C Sheppard. Advancing America's Right to Health. Globe & Mail, June 2012.

Barkun AN, Bardou M & International Consensus Upper Gastro Bleeding Conference Group.  International Consensus Recommendations on the Management of Patients with Nonvarceal Upper Gastrointestinal Bleeding. Ann Intern Med 2010;152(2):101-13 (ethics co-author)

"Interface of Law and Ethics in Canadian Research Ethics Standards: An Advisory Opinion on Confidentiality, its Limits & Duties to Others." [.pdf], McGill Health Law Publication 2007;1:101-116.

Interagency Advisory Panel & Secretariat on Research Ethics, Interpreting the TCPS, Volume II. Ottawa: Government of Canada, Dec. 2006. (contributing author).

Interagency Advisory Panel & Secretariat on Research Ethics, Process Principles for Ethics Governance Systems. Ottawa: Government of Canada [.pdf], 2002, 2006 (contributing author).

Interagency Advisory Panel & Secretariat on Research Ethics. Advisory Opinion: US Ethics Committee Review of Clinical Trials in Canada, 2003, (principal author).

Selected Legal Issues in Genetic Testing: Guidance from Human Rights [.pdf]. Ottawa: Health Canada, 2001, 85 pp.

Selected International Legal Norms on the Protection of Personal Information in Health Research Ottawa: Public Works Canada/Canadian Institutes of Health Research, 2001, 78 pp., (co-author, Julie Cote). 

Towards a Coherent Ethics Framework for Biotechnology in Canada [.pdf], Canadian Biotechnology Advisory Committee, Ottawa: Government of Canada, 1999.

Ethical & Legal Issues in the Supply of Blood Products: Should We Sell Blood? Bayer Advisory Council on Bioethics. Toronto, 1999, 110 pp.

"Ethics and Biotechnology: The Role of the Government of Canada" [.pdf] in Renewal of the Canadian Biotechnology Strategy Roundtable Consultation -- Background Documents. Ottawa: Government of Canada 1998:1-69.

"Health Law & Bioethics: Requiem or Renaissance for the Law Reform Commission of Canada" [.pdf] (1995) 46 International Digest Health Legislation 117; reprinted with modifications in Annals of the Royal College of Physicians & Surgeons of Canada 1996:29(3):167-70.

"Conflict of Interest in Research Ethics" [.pdf] National Council on Bioethics in Human Research Communiqué CNBRH 1995/6(2):5-10.

"Retrospectives on the Future: Brain Death and Evolving Legal Regimes for Tissue Replacement Technology" [.pdf] (1993) 38 McGill Law Journal 396-415.

Procurement & Transfer of Human Tissues & Organs, Law Reform Commission of Canada (1992), 230 pp. (principal author). See the Introduction [.pdf], Legal Review  PDF icon jones_dj_tissue_procument_law_c3_legal_lrcc92-1.pdf[pdf] and Recommendations [.pdf].

"Brief of The Law Reform Commission of Canada to the Royal Commission on New Reproductive Technologies" [.pdf] (1992) 13(1) Health Law in Canada 119-124 (principal author).

"AIDS & Disability Employment Discrimination in & Beyond the Classroom" [.pdf] (1989) 12(1) Dalhousie Law Journal 103-130 (co-author, Colleen Sheppard).

"Artificial Procreation, Societal Reconceptions: Legal Insight from France" [.pdf] (1988) 36(3) American J. Comparative L. 525-545. 

Lara Khoury

Le juge canadien, anglais et australien devant l’incertitude causale en matière de responsabilité médicale” (2014) 59:4 Revue de droit de McGill 989.

« Infections associées aux soins dans les établissements de santé québécois » in Mélanie Bourassa Forcier & Anne-Marie Savard, eds, Droit et politiques de la santé (LexisNexis Canada, Oct. 2014, 442 pp)

"Healthcare-associated Infections", in Yann Joly & Bartha Maria Knoppers, eds, Routledge Handbook of Medical Law and Ethics (Routledge, 2015, 480 pp)

« Faute, responsabilité et médecine moderne » in B. Moore ed., Mélanges en l’honneur de Jean-Louis Baudouin (Cowansville : Yvon Blais, 2012).

« Innovation biomédicale et évolution du droit de la responsabilité civile : une étude comparée France-Québec » in E. Vergès (ed.), Droit, sciences et techniques, quelles responsabilités ?, Coll. Colloques et débats (Paris : Lexis Nexis Litec, 2011).

avec M. Iokheles, “Factual Causation and Healthcare-Associated Infections” (2009) 17 Health Law Journal 195.

« Une nouvelle révolution pour le droit de la responsabilité civile » (2009) 39 Revue générale de droit 51.

« Le respect des volontés anticipées de fin de vie : entre jugement clinique et droit » (2008) 87 Canadian Bar Review 37.

"Causation and Risk in the Highest Courts of Canada, England, and France" (2008) 124 Law Q. Rev. 103-131

"Causation in Medical, Environmental and Product Liability". (2007) 25:1 Windsor Yearbook of Access to Justice 135.

"Genetic Testing and GMO Escape: The Patent Holder's Duty to Inform" in Phillips, P. and C. Onwuekwe, eds. Accessing and Sharing the Benefits of the Genomics Revolution. Springer/Kluwer (Forthcoming)

"Chester v. Afshar: Stepping Further Away from Causation?" (2005) Singapore Journal of Legal Studies 246.

Uncertain Causation in Medical Liability (Oxford: Hart Publishing, 2006 and Cowansville: Yvon Blais, 2006).

« L’impact des présomptions de faute et de la responsabilité sans égard à la faute sur la preuve de la causalité en responsabilité médicale » in T. Bourgoignie, ed. Accidents thérapeutiques et protection du consommateur. Vers une responsabilité sans faute au Québec? (Cowansville : Yvon Blais, 2006).

Nicholas King

with Robin Richardson, Thomas Charters & Sam Harper, “Trends in educational inequalities in drug poisoning mortality in the United States, 1994-2010.” (2015) 105:9 American Journal of Public Health 1859.

“Mediating Panic: The Iconography of New Infectious Threats, 1936-2009” in Robert Peckham, ed, Empires of Panic: Epidemics and Colonial Anxieties (Hong Kong: Hong Kong University Press, 2015) 181.

with Veronique Fraser, Constantina Boikos et al, “Determinants of Increased Opioid-Related Mortality in the United States and Canada, 1990-2013: A Systematic Review” (2014) 104:8 American Journal of Public Health e32.

with Kristin Voigt, “Disability Weights in the Global Burden of Disease 2010: Two Steps Forward, One Step Back?” (2014) 92 Bulletin of the World Health Organization 226, available online.

“Contagion: A Misnomer for Financial Crisis.” (2014) 36(1) Journal of Public Health 18, available online.

with Sam Harper & Meredith Young, “Impact of Selective Evidence Presentation of Health Inequality Trends: An Experimental Study” (2013) 8:5 PLOS ONE e63332, available online.

with Veronique Fraser, “Untreated Pain, Narcotics Regulation, and Global Health Ideologies” (2013) 10:4 PLOS Medicine e1001411 (PLOS Medicine Weekly Editor’s Pick), available online.

with Meredith E Young, Sam Harper & Karin R Humphreys, “The influence of popular media on perceptions of personal and population risk in possible disease outbreaks” (2013) 15:1 Health, Risk, and Society 103.

with Sam Harper & Meredith E Young, “Who Cares About Health Inequalities? Cross-country Evidence from the World Health Survey” (2013) 28:5 Health Policy and Planning 558, available online.

“Invited Commentary - Biodefense and the Production of Knowledge: Rethinking the Problem.” (2013) 39 Journal of Medical Ethics 207, available online.

with Sam Harper & Meredith E Young, “Use of relative and absolute effect measures in reporting health inequalities: structured review” (2012) 345 BMJ e5774, available online.

“Case Discussion: Health Inequities in First Nations Communities and Canada’s Response to the H1N1 Influenza Pandemic” in Canadian Institutes of Health Research - Institute of Population and Public Health, Population and Public Health Ethics: Cases from Research, Policy, and Practice (Toronto, ON: University of Toronto Joint Centre for Bioethics, 2012) 153.

“Equality and Inequality in American Health Care (Revised)” in Eileen E Morrison, ed, Health Care Ethics: Critical Issues for the 21st Century (Sudbury, MA: Jones & Bartlett, 2012) 339.

Introduction to the reprint of “The Influence of Anxiety: September 11, Bioterrorism, and American Public Health” in John Charles Goshert, ed, Entering the Academic Conversation (Glenview, IL: Pearson, 2011) 369.

with Sam Harper et al, “Implicit Value Judgments in the Measurement of Health Inequalities” (2010) 88:1 Milbank Memorial Fund Quarterly 4.

with Sam Harper, Scan of Scenario Building in Population Health With a Focus on Social Determinants Of Health (Ottawa: Public Health Agency of Canada, 2009).

with Daniel B Ornt, David C Aron et al, “Population Medicine in a Curricular Revision at Case Western Reserve” (2008) 83:4 Academic Medicine 327, available online.

“Networks, Disease, and the Utopian Impulse” in Ali S Harris Ali & Roger Keil, eds, Networked Disease: Emerging Infections in the Global City (Malden, MA: Wiley-Blackwell, 2008) 201.

with Allison Aiello & Betsy Foxman, “Antimicrobial Resistance and the Ethics of Drug Development” (2006) 96:11 American Journal of Public Health 1910, available online.

with Jessica W Berg, “Strange Bedfellows? Reflections on Bioethics' Role in Disaster Response Planning” (2006) 6 American Journal of Bioethics 3.

“The Ethics of Biodefense” in Michael J Selgelid et al, eds, Ethics and Infectious Disease (Malden, MA: Blackwell, 2006) 352. 

“The Ethics of Biodefense” (2005) 19:4 Bioethics 432.

Alana Klein

“Participation and Accountability: New Avenues for Human Rights Engagement with the Distribution of Health Resources in Canada” in Advancing Social Rights in Canada, Martha Jackman and Bruce Porter, eds. (Irwin Law, August 2014, 442 pp)

"Criminal Law, Public Health, and Governance of HIV Exposure and Transmission" (2009) 13 International Journal of Human Rights 251.

Sticking Points: Barriers to Access to Needle and Syringe Programs in Canada. (Toronto: Canadian HIV/AIDS Legal Network, 2007).

Antonia Maioni

Antonia Maioni. Health Care in Canada. (OUP Canada, October 2014, 160 pp)

with R Nadeau, E Belanger, S Soroka & F Petry, Health Care Policy and Opinion in the United States and Canada (New York: Routledge, 2014).

"Health Care in Canada and the United States” in David M Thomas and David N Biette, eds, Canada and the United States: Differences that Count (Toronto: University of Toronto Press, 2014) 254.

“Canada” in James A Morone and Dan Ehlke, eds, Health Politics and Policy (Stamford, CT: Nelson/Cengage, 2014) 398.

with S Soroka & P Martin, “What Moves Public Opinion on Health Care?” (2013) 38:5 Journal of Health Politics, Policy and Law 893.

“Health Care” in Herman Bakvis and Grace Skogstad, eds, Canadian Federalism, 3rd ed (Toronto: Oxford University Press, 2012) 165.

“Transformación del Estado de bienestar canadiense” in Gustavo Vega Cánovas & Irina Alberro, eds, Canadá: Gobernabilidad democrática y política exterior in una época de crisis y cambio internacionales (México: El Colegio de México, 2011) 127.

“Citizenship and Health Care” (2010) 42 International Journal of Canadian Studies 225.

“Health Care in Quebec”, in Quebec Questions: Quebec Studies for the Twenty-First Century, ed. Jarrett Rudy et al. (Oxford University Press, 2010).

“Health care reform in the 2008 US presidential election” (2009) 64:1 International Journal 135.

with T.R. Marmor, “Health Care in Crisis: What’s Driving Health Reform in Canada and the United States?” (2008) 9 One Issue, Two Voices (Washington, DC: Woodrow Wilson International Center for Scholars).

with C. Manfredi, « L’arrêt Chaoulli et la judiciarisation des politiques de santé » in François Béland, Le privé dans la santé : Les discours et les faits (Les Presses de l’Université de Montréal, 2008) 264.

“Health Care in Canada” in Herman Bakvis & Grace Skogstad, eds, Canadian Federalism, 2nd ed (Toronto: Oxford University Press, 2008) 161.

Christopher Manfredi

with Antonia Maioni, “Judicializing Health Policy: Unexpected Lessons and an Inconvenient Truth” in James Kelly & Christopher Manfredi, eds, Contested Constitutionalism: Reflections on the Charter of Rights and Freedoms (Vancouver: University of British Columbia Press, 2009) 129.

with Antonia Maioni, “L’arrêt Chaoulli et la judiciarisation des politiques de santé” in François Béland, ed, Le privé dans la santé : Les discours et les faits (Montreal: Les Presses de l’Université de Montréal, 2008) 264.

with Antonia Maioni, “The Last Line of Defence for Citizens: Litigating Private Health Insurance in Chaoulli v. Québec” (2006) 44:2 Osgoode Hall Law Journal 249. Read online.

with Antonia Maioni, “Les litiges fondés sur les droits et l’émergence du rôle des tribunaux dans l’élaboration des politiques en matière de santé” (2006) 11:1 Ruptures: Revue transdisciplinaire en santé 32. Read online [.pdf].

“Déjà Vu All Over Again: Chaoulli and the Limits of Judicial Policymaking” in Colleen Flood, Lorne Sossin & Kent Roach, eds, Access to Care, Access to Justice: The Legal Debate Over Private Health Insurance in Canada (Toronto: University of Toronto Press, 2006) 139.

with Antonia Maioni, “Reversal of Fortune: Litigating Health Care Reform in Auton v. British Columbia” (2005) 29 SCLR (2d) 111. Read online.

with Antonia Maioni, “When the Charter Trumps Health Care - A Collision of Canadian Icons” (2005) 26:7 Policy Options 52. Read online [.pdf].

with Antonia Maioni, “Litigating Innovation: Health Care Policy and the Canadian Charter of Rights and Freedoms” (Paper deliver at the Annual Meeting of the Canadian Political Science Association, London, ON, 4 June 2005). Read online [.pdf].

Margaret A. Somerville

“Law Marching with Medicine but in the Rear and Limping a Little: Ethics as ‘First Aid’ for Law” in Silja Voneky, Britta Beylage-Haarmann, Anja Holfelmeier & Anna-Katharina Hubler, eds, Ethik und Recht – Die Ethisierung des Rechts (Ethics and Law – The Ethicalization of Law) (Heidelberg: Springer, 2013) 67.

with Donald J Boudreau, “Euthanasia is not medical treatment” (2013) 106 British Medical Bulletin 45.

with Donald J Boudreau, “Physician-Assisted Suicide Should Not Be Permitted” (2013) 368:15 New England Journal of Medicine 1450.

“Bioethics: A Forum for Finding Shared Values in a Twenty-first Century Society” in Douglas Shantz & Tinu Ruparell, eds, Christian Thought in the Twenty-First Century: Agenda for the Future (Eugene, Oregon: Cascade Books, 2012) 114.

“Children’s Human Rights to Natural Biological Origins and Family Structure” (2011) 1 International Journal of the Jurisprudence of the Family 35.

“Donor conception and children’s rights: ‘First, do no harm’” (2011) 183:2 Canadian Medical Association Journal 280.

“Dying as the Last Great Act of Living : Keeping Euthanasia Out to Keep Death and Dying in a Moral Context” in Marc Cardinal Ouellet, Margaret Somerville, Richard Habner & Paula Diadori, eds, A Personal Matter: Essays on the Foundation and Defense of Human Dignity in Medicine and Society (Ottawa: Justin Press, 2010) 93.

"An update from the 16th Ontario provincial Conference on palliative and End of Life Care", Oncology Exchange Vol 5 No 4, October 2006

"Public Health, Biosecurity and Ethics", Scientific Working Group on Life Science Research and Global Health Security, World health Organization; Geneva, 2006

The Ethical Imagination: Journeys of the Human Spirit, House of Anansi Press, Toronto, 2006

"The Ethics of Immortalizing Our Genetic Selves", chapter 3, pp. 41-76 in Ethics of science and technology: Explorations of the frontiers of science and ethics, UNESCO; Paris, 2006

"Sex ratio in India", Correspondence, The Lancet, 2006; 367: 1725

"New Technoscience and New Kinds of Respect for Life: Human Embryo Stem Cell Research and Therapeutic Cloning as Case Studies", Medical Biotechnology Research, 2006; 1 (4): 3-5

"The Importance of Empirical Research in Bioethics: The Case of Human Embryo Stem Cell Research", Journal of Obstetrics and Gynaecology Canada 2005; 27: 929- 930; "Importance de la recherche empirique en bioéthique : Cas de la recherche sur les cellules souches embryonnaires humaines", Journal d’obstétrique et gynécologie du Canada 2005; 27 : 931-932

"The Troublesome Ethics of Biosecurity", Epilogue, McGill News, Volume 85, No 3, Fall 2005, p.48

"Valeurs socio-éthiques et débat politique", Le banquet, Revue du CERAP No 22, September 2005, pp. 333-349

with Ronald Atlas, "Using Ethics to Fight Bioterrorism" Science 2005; 309: 1014-1017

"The Ethical Complexity of the Terry Schiavo Case", Canadian Disability, Summer/Fall 2005: 5-6

with Ronald Atlas, "Ethics: A Weapon to Counter Bioterrorism" Science 2005; 307: 1881-1882

"Prenatal diagnosis", Correspondance, The Lancet 2005; 366: 1162

Preface, Dr. Maya and Kathryn Garforth, "International Public Health and Trade Law", in Markus W. Gehring and Marie-Claire Cordonier Segger (eds), Sustainable Development in World Trade Law, Kluwer Law International 2005

"The Ethics of Biosecurity", (2005) Project Syndicate

"Preventing the Horrifying", (Interinvest Newsletter) April 2005

"Social-Ethical Issues and Elections", (Interinvest Newsletter), March 2005

Ma’n Zawati

with E. Cohen, D. Parry, D. Avard & D. Syncox, “Ethics Education for Clinician-Researchers in Genetics: The Combined Approach” (2014) Applied and Translational Genomics Journal.

with B.M., Knoppers, D. Avard & K. Sénécal, “Return of Whole-Genome Sequencing Results in Paediatric Research: A Statement of the P3G International Paediatrics Platform” (2014) 22:1 European Journal of Human Genetics, 3.

with D. Parry, A. Thorogood, M.T. Nguyen, K. Boycott, D. Rosenblatt & B.M. Knoppers, “Reporting Results from Whole-Genome and Whole-Exome Sequencing in Clinical Practice: A Proposal for Canada?” (2014) 51:1 Journal of Medical Genetics, 68.

with A.L. McGuire, B.M. Knoppers & E.W. Clayton, “Can I be Sued for that? Liability Risk and the Disclosure of Clinically Significant Genetic Research Findings” (2014) 24:5 Genome Research, 719.

with T Caulfield et al, “A review of the Key Issues Associated with the Commercialization of Biobanks” (2014) 1:1 Journal of Law and the Biosciences 94.

with ES Dove & BM Knoppers, “Towards an Ethics Safe Harbor for Global Biomedical Research” (2014) 1:1 Journal of Law and the Biosciences 3.

with BM Knoppers & E Cohen, “Special Issue - From Biobanks to the Clinic” (2014) 3:2 Applied & Translational Genomics 21.

with A Thorogood & BM Knoppers, “Point-of-Care Genetic Tests for Infectious Disease: Legal Considerations” (2014) 12:1 Current Pharmacogenomics and Personalized Medicine 43.

“Liability and the Legal Duty to Inform in Research” in Y Joly and BM Knoppers, eds, Routledge Handbook of Medical Law and Ethics (London: Routledge, 2014) Chapter 12.

with A Thorogood, “The physician who knew too much: A comment on Watters v White” (2014) 21 Health Law Journal 1.

“Éléments de la responsabilité civile du conseiller en génétique au Québec” in Anne Marie Savard & Mélanie Bourrassa Forcier, eds, Droit et politiques de la santé (Quebec: LexisNexis Canada, 2014) 351.

with D Parry & BM Knoppers, “The best interests of the child and the return of results in genetic research: international comparative perspectives” (2014) 15:72 BMC Medical Ethics 1.

“There will be sharing: Population Biobanks, the duty to inform and the limitations of the individualistic conception of autonomy” (2014) 21 Health Law Journal 97.

with L. Black, D. Avard, B.M. Knoppers, J. Hébert & G. Sauvageau, “Funding Considerations for the Disclosure of Genetic Incidental Findings in Biobank Research” (2013) 84:5 Clinical Genetics, 397.

with B.M. Knoppers & E.S. Dove, “Demystifying Biobanks” (2013) 43:5 Hastings Center Report, 4.

with ES Dove & BM Knoppers, “An Ethics Safe Harbor for International Genomics Research?” (2013) 5:11 Genome Medicine 99.

with E Kirby & BM Knoppers, “Electronic Consent to Health Research in Canada” (2013) 91:2 Canadian Bar Review 417.

with BM Knoppers & A Rioux, “Pediatric Research ‘Personalized’? International Perspectives on the Return of Results” (2013) 10:1 Personalized Medicine 89.

with K Senecal et al, “RMGA Statement of Principles on the Return of Research Results and Incidental Findings” (Montréal, RMGA, 2013). Available at http://www.rmga.qc.ca/en/documents/RMGAStatement_Principles_English_May272013_000.pdf

“Biobanques destinées à la recherche: introduction et défis majeurs” in Actes, 6e édition, Journées d’étude des comités d’éthique de la recherche et de leurs partenaires (Quebec, La Direction des communications du ministère de la Santé et des Services sociaux, 2013) 20-25.

with A.M. Tassé, “To Share or Not to Share? Secondary Use in Public Health Emergencies” in Population and Public Health Ethics: Cases from Research, Policy, and Practice, Canadian Institutes of Health Research – Institute of Population and Public Health, (Toronto, ON: University of Toronto Joint Centre for Bioethics, 2012).

with B.M. Knoppers, M. Deschênes, A.M. Tassé, “Population studies: return of research results and incidental findings: Policy statement” (2012) European Journal of Human Genetics.

with B.M. Knoppers & E.S. Kirby, “Sampling Populations of Humans Across the World: ELSI Issues” (2012) 13:1 The Annual Review of Genomics and Human Genetics 1.

with B.M., Knoppers, “Biobanks” in Encyclopedia of Applied Ethics, 2nd ed (San Diego: Academic Press, 2012) 246.

“Les conseillers en génétique et les professions médicales et infirmières au Québec: des frontières brouillées ?” (2012) 6:1 MJLH 137.

with B.M., Knoppers, “International Normative Perspectives on the Return of Individual Research Results and Incidental Findings in Genomic Biobanks” (2012) 14:4 Genetics in Medicine 484.

with A. Rioux, “Les biobanques et le retour des résultats de recherche : quo vadis ?” (2012) Actions pour la santé et la recherche médicale en faveur des personnes vulnérables et des pays émergents - Vie Forum des jeunes chercheurs.

with Y. Joly, G. Koutrikas, E. Ramos-Paque & J. Gardy, “Diagnostic Testing for Vaccinomics: Is the Regulatory Approval Framework Adequate? A Comparison of Canada, the United States and Europe” (2011) 15:9 OMICS.

with B.M. Knoppers, “De l'éthique et des avocats: les comités d'éthique dans le milieu hospitalier” in Éthique, profession juridique et société - Collection de droit 2011-2012, volume hors série, École du Barreau (Cowansville: Éditions Yvon Blais, 2011).

with B.M. Knoppers, “Population Biobanks and Access” in S. Rodota, P. Zatti (eds.), Il Governo del Corpo: Trattato di Biodiritto, Giuffrè Editore, 1181.

with V. Ozdemir, T. Pang, B.M. Knoppers, D. Avard, S.A. Faraj, E. Kolker, “Vaccines of the 21st Century and Vaccinomics: Data-Enabled Science Meets Global Health to Spark Collective Action for Vaccine Innovation” (2011) 15(9) OMICS.

with P. Borry & H.C. Howard, “Closure of population biobanks and direct-to-consumer genetic testing companies” (2011) 130:3 Human Genetics 425.

with M. Hendy & Y. Joly, “Incidental Findings in Data Intensive Postgenomics Science and Legal Liability of Clinician-Researchers: Ready for Vaccinomics” (2011) 15:9 OMICS.

with B.M. Knoppers & A. Rioux, “Guidance for Biobanks: Models of Consent for Public Health” Report submitted to the Public Health Agency of Canada (PHAC), 18 March 2011.

with A. Rioux, “Biobanks and the Return of Research Results: Out with the Old and In with the New?” (2011) 39:4 JLME, 614.

with B. Van Ness & B.M. Knoppers, “Incidental findings in genomic research: a review of international norms”(2011) 9:1 GenEdit 1.

“La pharmacogénomique et la responsabilité civile des médecins” in Droit de la santé publique dans un contexte translational: IVe forum des jeunes chercheurs (Bordeaux Centre, Les Études Hospitalières, 2010).

Key Ethical Considerations in the Development of Guidelines for the Biobanking of Human Biological Materials: A Discussion Paper. Référence, Report submitted to the Public Health Agency of Canada (PHAC), 31 March 2010.

with B.M. Knoppers “Health Privacy in Genetic Research: Populations and Persons” (2009) 28:2 Politics and the Life Sciences 99.

 

Tags: